Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.Philipp L Goerttler, Heike L. Pahl, E März et al.|PubMed|2005Cited by 13
Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL StudyRalph V. Boccia, Alison R. Moliterno, Ahmad Naim et al.|Blood|2015Cited by 11
Self-Reported Quality-of-Life Impairment and Productivity Loss in Patients with Polycythemia Vera: Early Patient-Reported Outcomes Assessment from the REVEAL StudyRuben A. Mesa, Brady L. Stein, Ralph V. Boccia et al.|Blood|2015Cited by 2
Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL StudyBrady L. Stein, Ruben A. Mesa, Ahmad Naim et al.|Blood|2016Cited by 2
Self-reported quality-of-life (QoL) impairment and productivity loss in patients with polycythemia vera (PV) enrolled in the REVEAL study.Michael R. Grunwald, Ruben A. Mesa, Ralph V. Boccia et al.|Journal of Clinical Oncology|2016Cited by 1